Response to once-a-day Visken dosage
Bjerle, P.
Medical Journal of Australia 2(Sp2): 15-19
1977
ISSN/ISBN: 0025-729X PMID: 337072 Document Number: 114344
Document emailed within 1 workday
Related Documents
Chrástek, J.; Kavánková, M. 1976: Effect of beta-adrenergic blockade (Visken) on heart rate orthoclinostatic response and on hypertensive pressor reflex in a mental exertion model Sbornik Lekarsky 78(5): 133-140Ito, N.; Shirai, T.; Tagawa, Y.; Nakamura, A.; Fukushima, S. 1988: Variation in tumor yield in the prostate and other target organs of the rat in response to varied dosage and duration of administration of 3,2'-dimethyl-4-aminobiphenyl Cancer Research 48(16): 4629-4632
Martinenghi, C.; Mombelli, L.; Cosentino, D.; Cinquepalmi, N.; Inversini, G. 1976: Distribution of dosage and estimation of dosage absorbed by critical organs in the fields of irradiation of lymphomas La Radiologia Medica 62(7-8): 548-552
Molnár, K.; Kömíves, S.; Kalmár, J.; Gerzon, J. 1978: The use of the drug combination of hypothiazide+Visken+Halidor in hypertension Therapia Hungarica 26(3): 132-134
Zdichynec, B. 1977: Treatment of supraventricular arrhythmias using the beta-blockader Visken Zeitschrift für Arztliche Fortbildung 71(10): 478
Komarov, F.I.; Kun, I.S.; Markova, V.M.; Mytareva, I.L.; Ostrovskaia, V.I. 1977: Experience in using visken in ischemic heart disease and arterial hypertension Sovetskaia Meditsina 1: 53-55
Korkushko, O.V.; Shatilo, V.B.; Butenko, A.G. 1989: Effectiveness of tobanum and visken in ischemic heart disease with extrasystole Sovetskaia Meditsina 12: 66-68
Schwartz, R.H.; Merryman, C.F.; Maurer, P.H. 1979: Gene complementation in the T lymphocyte proliferative response to poly (Glu57Lys38Tyr5): evidence for effects of polymer handling and gene dosage Journal of Immunology 123(1): 272-278
Liang, F.M.; Yang, T.; Dong, L.; Hui, J.J.; Yan, J. 2017: The predictive value of dynamic arterial elastance in arterial pressure response after norepinephrine dosage reduction in patients with septic shock Zhonghua Nei Ke Za Zhi 56(5): 344-348
Musial, W.; Tracz, W.; Krzemińska-Pakula, M. 1971: New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease Polski Tygodnik Lekarski 26(22): 834-836
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Ohnhaus, E.E.; Münch, U.; Meier, J. 1976: Comparative study on the elimination of pindolol (visken) and antipyrin in patients with liver diseases Schweizerische Medizinische Wochenschrift 106(49): 1748-1750
Cherot, A.; Amor, B. 1983: Treatment of algodystrophy. a randomized study of 95 cases with 3 treatments: Calsyn 100, Visken, Grisefuline and Penthonium Revue du Rhumatisme et des Maladies Osteo-Articulaires 50(2): 95-97
Friedemann, M. 1975: Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken) Schweizerische Medizinische Wochenschrift 105(30): 957-961
Sonkodi, S.; Pap, A.; Varró, V. 1976: Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes Therapia Hungarica 24(2): 60-62
Adamska-Dyniewska, H. 1973: Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol) Wiadomosci Lekarskie 26(13): 1201-1205
Gotze, D. 1976: Serological characterization of ia immune response associated antigens of the h 2 k h 2 s and h 2 q haplotypes by anti sera produced against skin lymphocytes and lympho blasts strain distribution pattern of ia immune response associated antigens and their relationship to ir immune response genes Immunogenetics 3(2): 139-156
Odom, A.; Gross, W.B.; Ehrich, M. 1992: Role of socialization, stress and sex of chickens on response to anesthesia and on response to an organophosphate neurotoxicant Veterinary and Human Toxicology 34(2): 134-137
Yoshimasu, T.; Oura, S.; Hirai, I.; Kokawa, Y.; Okamura, Y.; Furukawa, T. 2005: Dose response curve of paclitaxel measured by histoculture drug response assay Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(4): 497-500
Splinter, T.; Denis, L. 1990: Restaging procedures, criteria of response, and relationship between pathological response and survival Seminars in Oncology 17(5): 606-612